These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 11125287)

  • 1. [Immunotargeting of tumors: state of the art and prospects in 2000].
    Pèlegrin A; Xavier F; Barbet J; Bartholeyns J; Baty D; Buchegger F; Chatal JF; Dufief F; Gurreau D; Gruaz-Guyon A; Lamotte D; Leserman L; Mach JP; Robert B; Saccavini JC; Teillaud JL; Teulon I
    Bull Cancer; 2000 Nov; 87(11):777-91. PubMed ID: 11125287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioimmunotargeting: diagnosis and therapeutic use].
    Vuillez JP
    Bull Cancer; 2000 Nov; 87(11):813-27. PubMed ID: 11125290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
    Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
    J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
    Pavlinkova G; Booth BJ; Batra SK; Colcher D
    Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
    Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of antibodies or their fragments for the treatment of tumors].
    Douillard JY; Chatal JF
    Bull Cancer; 1998 Nov; 85(11):951-9. PubMed ID: 9951422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody.
    Sharkey RM; Karacay H; Chang CH; McBride WJ; Horak ID; Goldenberg DM
    Leukemia; 2005 Jun; 19(6):1064-9. PubMed ID: 15815716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-guided radiation therapy of cancer.
    Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
    Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
    Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoconjugates for the treatment of cancer.
    Kraeber-Bodéré F; Bodet-Milin C; Rousseau C; Eugène T; Pallardy A; Frampas E; Carlier T; Ferrer L; Gaschet J; Davodeau F; Gestin JF; Faivre-Chauvet A; Barbet J; Chérel M
    Semin Oncol; 2014 Oct; 41(5):613-22. PubMed ID: 25440606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The promise of immuno-PET in radioimmunotherapy.
    Verel I; Visser GW; van Dongen GA
    J Nucl Med; 2005 Jan; 46 Suppl 1():164S-71S. PubMed ID: 15653665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments.
    Carrasquillo JA; Krohn KA; Beaumier P; McGuffin RW; Brown JP; Hellström KE; Hellström I; Larson SM
    Cancer Treat Rep; 1984 Jan; 68(1):317-28. PubMed ID: 6607111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy of non-Hodgkin's lymphoma: molecular targeting and novel agents.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 Mar; 20(2):87-93. PubMed ID: 17440631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of radioimmunotherapy in the new millennium.
    Imam SK
    Cancer Biother Radiopharm; 2001 Jun; 16(3):237-56. PubMed ID: 11471488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoimaging and radioimmunotherapy: will these be routine procedures?
    Bischof Delaloye A
    Semin Nucl Med; 2000 Jul; 30(3):186-94. PubMed ID: 10928382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.
    Engert A; Martin G; Pfreundschuh M; Amlot P; Hsu SM; Diehl V; Thorpe P
    Cancer Res; 1990 May; 50(10):2929-35. PubMed ID: 1692251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of therapy of solid tumors.
    Jhanwar YS; Divgi C
    J Nucl Med; 2005 Jan; 46 Suppl 1():141S-50S. PubMed ID: 15653662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoscintigraphy and radioimmunotherapy of cancer using monoclonal antibodies].
    Oriuchi N
    Gan To Kagaku Ryoho; 1999 May; 26(6):762-7. PubMed ID: 10410144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.